Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MEYERING, SHABANA SHABBEER | 1 | 69.2% | +41.6% |
| GODDARD, LAURA B | 1 | 50.9% | +14.1% |
| ZOU, NIANXIANG | 1 | 64.0% | +24.4% |
| BUCKMASTER, MARLENE VRENI | 1 | 28.6% | +77.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17607383 | ANTIBODIES AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION | BUCKMASTER, MARLENE VRENI | 147d overdue |
| 18262872 | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS INFECTION | GODDARD, LAURA B | 21d |
| 18559756 | COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS | MEYERING, SHABANA SHABBEER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17607383 | ANTIBODIES AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION | BUCKMASTER, MARLENE VRENI | 147d overdue |
| 18262872 | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS INFECTION | GODDARD, LAURA B | 21d |
| 17611063 | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS (HBV) INFECTION | ZOU, NIANXIANG | 34d |
| 18559756 | COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS | MEYERING, SHABANA SHABBEER | — |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| 1642 | 1 |
| 1671 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18559756 | COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS | MEYERING, SHABANA SHABBEER | 1635 | §103§112 | Non-Final OA | — | Pending | Nov 08, 2023 |
| 18262872 | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS INFECTION | GODDARD, LAURA B | 1642 | §102§103§112Other | Non-Final OA | 21d | Pending | Jul 25, 2023 |
| 17611063 | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS (HBV) INFECTION | ZOU, NIANXIANG | 1671 | §103 | Non-Final OA | 34d | Pending | Nov 12, 2021 |
| 17607383 | ANTIBODIES AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION | BUCKMASTER, MARLENE VRENI | 1672 | §103Other | Final Rejection | 147d overdue | Pending | Oct 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial